Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

NCT04816591 is registered in ClinicalTrials.gov with Cerenovus, Part of DePuy Synthes Products, Inc. as lead sponsor.

NCT NCT04816591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04816591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA
Lead sponsor
Cerenovus, Part of DePuy Synthes Products, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 27, 2021
Completion date
March 26, 2025
Enrollment
376 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

chronic subdural hematoma